Eventide Asset Management
Investor profile
Eventide Asset Management has backed 2 European tech companies across 3 funding rounds between 2020 and 2022, joining rounds totalling €306M. Most active in Healthtech. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
2
backed
Active span
2020–2022
3 yrs
Total round €
€306M
sum of rounds joined
Deals by year
distinct rounds / yearEventide Asset Management — deals by year — interactive chart.
Data table
| Eventide Asset Management — deals by year | |
|---|---|
| 2020 | 2 |
| 2022 | 1 |
Top sectors
by dealsEventide Asset Management — top sectors — interactive chart.
Data table
| Eventide Asset Management — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsEventide Asset Management — stages — interactive chart.
Data table
| Eventide Asset Management — stages | |
|---|---|
| Series C | 2 |
| Other | 1 |
Countries
by dealsEventide Asset Management — countries — interactive chart.
Data table
| Eventide Asset Management — countries | |
|---|---|
| UK | 2 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Freeline Therapeutics | UK | 2 | €178M |
| Vectivbio | Switzerland | 1 | €127M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Vectivbio | Other | €127M | 2022-10 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| Freeline Therapeutics | Series C | €71M | 2020-07 |